A breast-cancer diagnosis becomes easier to discuss when you separate three questions: what the tissue sample shows, how far the cancer extends, and which treatments fit its biology. Start by getting your reports and identifying which results are still pending.
This guide is for someone with a new diagnosis and the people helping them. If you are investigating a lump or another change, begin with breast changes and examinations. An abnormal screening result begins an evaluation; the diagnosis depends on the clinical work-up.
Start with the exact diagnosis
A biopsy provides tissue that a pathologist examines. Ask for the complete pathology report and any later addendum, including biomarker results. The National Cancer Institute's diagnosis guide explains how examination, imaging and tissue testing answer different questions.
Write down the precise name of the finding. Invasive cancer has grown into surrounding breast tissue; ductal carcinoma in situ (DCIS) describes abnormal cells contained within the ducts. These findings lead to different conversations. If a report uses unfamiliar terms, ask your team to translate them before comparing your experience with someone else's.
On a small screen, scroll the table sideways. Keyboard users can focus the table region and use the arrow keys.
| Report item | What it helps explain | Question to bring |
|---|---|---|
| Type and invasiveness | The tissue diagnosis and whether cells have extended beyond their original location. | What is the full name of my diagnosis? |
| Grade | How abnormal the cancer cells look under a microscope. | What does the grade add to the treatment discussion? |
| Stage | The extent of disease, considered with tumor biology in breast cancer. | What is my current stage, and what information could refine it? |
| ER, PR and HER2 | Tumor features that help guide treatment choices. | Are all results final, or is another test pending? |
Keep grade and stage in separate places in your notes. A high grade alone does not tell you where the cancer has spread. NCI's staging explanation describes how tumor size, nodes, distant spread, grade and biomarkers contribute. The team may refine its assessment as further information becomes available.
Use the explanation of local, regional and distant spread to prepare follow-up questions about staging. For imaging terminology, see mammogram assessments and callbacks.
Understand what biomarkers change
Estrogen receptor (ER) and progesterone receptor (PR) results help establish whether hormone signaling may support the cancer's growth. HER2 testing assesses a growth-related protein and, when needed, its gene. These results can point toward endocrine or HER2-directed treatments in appropriate settings. Keep the actual laboratory results, including scores, rather than reducing everything to a remembered label.
NCI's breast biomarker guide explains these tests and other tumor features. Triple-negative means the cancer lacks ER and PR and is HER2-negative by the relevant testing criteria; other treatment options may apply. A tumor biomarker test and a test for an inherited cancer-risk variant answer different questions. Ask whether genetic counseling or inherited-risk testing is appropriate for your history.
For a fuller explanation of family-risk assessment and result interpretation, use the inherited-risk and tumor testing comparison and its appointment worksheet.
Ask what each treatment is trying to accomplish
Local treatment acts on a particular area: surgery removes tissue, while radiation treats a defined region. Systemic treatments can reach cancer cells throughout the body. They include chemotherapy, endocrine therapy, targeted medicines and, in selected settings, immunotherapy. NCI's treatment overview connects these options with more detailed guidance.
Some treatment is given before surgery to shrink or treat the cancer; some follows surgery to reduce recurrence risk. Treatment for cancer that has spread to distant organs has a different planning context. Ask your team to name the goal and explain why its proposed sequence fits your results.
Make nutrition and daily support part of care
Food can support energy, strength and recovery. If appetite, nausea or weight changes make eating difficult, ask for an oncology dietitian. Bring a list of supplements and herbal products to the team because they can interact with treatment. NCI's diet and supplement guidance explains that dietary trends and supplements have not been shown to cure cancer or prevent its return.
Tell the team what matters in your daily life: caring responsibilities, work, travel to appointments, medication costs, fertility, sexual health, sleep or anxiety. Ask which professional can help with each concern and how to contact them. A practical obstacle deserves a plan just as a test result does.
For optional ways to express an experience, explore art, personal stories and professional art therapy.
Leave the next visit with a workable plan
- Bring reports, a medication/supplement list and your three most important questions. Invite someone to take notes if you wish.
- Ask what is known, what remains pending, and who will explain each outstanding result.
- Record the agreed next step, who arranges it and the expected date.
- Get the team's contact instructions, including whom to call about symptoms or treatment side effects between appointments.
- Repeat the plan in your own words so the team can correct misunderstandings.
Download the breast-cancer visit notes for a plain-text worksheet you can save or print. It includes spaces for the diagnosis, pending results, treatment goals and follow-up responsibilities.
Updated October 9, 2026. General education for preparing conversations with qualified health professionals; your care plan depends on your own history and test results.
Explore the Cancer guides and topic directory.